Terminated PHASE2 INTERVENTIONAL 1-arm NCT00982696

Treatment of Advanced Head and Neck Cancer

Treatment of Advanced Head and Neck Cancer With Opioid Growth Factors: Phase II

Sponsor: Milton S. Hershey Medical Center

Conditions Carcinoma, Squamous Cell of Head and Neck

Updated 7 times since 2017 Last updated: Sep 18, 2014 Started: Feb 29, 2008 Primary completion: Nov 30, 2011 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Deemed ineffective

Other terminated trials from Milton S. Hershey Medical Center

See all terminations from Milton S. Hershey Medical Center

Other Carcinoma, Squamous Cell of Head and Neck trials with similar outcome

Browse all Carcinoma, Squamous Cell of Head and Neck trials

A PHASE2 clinical study on Carcinoma, Squamous Cell of Head and Neck, this trial is terminated or withdrawn. The trial is conducted by Milton S. Hershey Medical Center and has accumulated 7 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Apr 2022 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Apr 2022 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Milton S. Hershey Medical Center

Data source: Milton S. Hershey Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hershey, United States